Glaxo Smithkline - Rixensart
FDA-inspected organization
Glaxo Smithkline - Rixensart has been audited by the FDA 11 times between 2000 and 2014 across all 1 sites.
Documents
FDA 483 Glaxo Smithkline - Rixensart, Rixensart | 2012
Out of stock
FDA 483 Glaxo Smithkline - Rixensart, Rixensart | 2010
Out of stock
FDA 483 Glaxo Smithkline - Rixensart, Rixensart | 2009
Out of stock
FDA 483 Glaxo Smithkline - Rixensart, Rixensart | 2008
Out of stock
FDA 483 Glaxo Smithkline - Rixensart, Rixensart | 2007
Out of stock
FDA 483 Glaxo Smithkline - Rixensart, Rixensart | 2007
Out of stock
FDA 483 Glaxo Smithkline - Rixensart, Rixensart | 2006
Out of stock
FDA 483 Glaxo Smithkline - Rixensart, Rixensart | 2004
Out of stock
FDA 483 Glaxo Smithkline - Rixensart, Rixensart | 2002
Out of stock
FDA 483 Glaxo Smithkline - Rixensart, Rixensart | 2000
Out of stock
FDA Investigators (18)
- Debra M. Emerson, FDA Investigator
- Omotunde O. Osunsanmi, FDA Investigator
- Cynthia Jim, FDA Investigator
- Paula A. Trost, FDA Investigator
- Christian Lynch, FDA Investigator
- Zhihao Pete Qiu, FDA Investigator
- Sean R. Byrd, FDA Investigator
- Jacqueline M. Diaz Albert, FDA Investigator
- Diaz Albert, Jacqueline M, FDA Investigator
- Pankaj H. Amin, FDA Investigator
- Jonathan McInnis, FDA Investigator
- Gang Wang, FDA Investigator
- Rebecca K. Olin, FDA Investigator
- Rose M. Ashley, FDA Investigator
- Mihaly S. Ligmond, FDA Investigator
- Sid B. Priesmeyer, FDA Investigator
- James C. Maclaughlin, FDA Investigator
- Kirsten L. Vadheim, FDA Investigator